156 related articles for article (PubMed ID: 9448053)
1. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.
Tsao FH; Meyer KC; Chen X; Rosenthal NS; Hu J
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):120-8. PubMed ID: 9448053
[TBL] [Abstract][Full Text] [Related]
2. Annexin I degradation in bronchoalveolar lavage fluids from healthy smokers: a possible mechanism of inflammation.
Vishwanatha JK; Davis RG; Rubinstein I; Floreani A
Clin Cancer Res; 1998 Oct; 4(10):2559-64. PubMed ID: 9796991
[TBL] [Abstract][Full Text] [Related]
3. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
4. Unopposed neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis.
Nunley D; Dauber J; Iacono A; Keenan R; Zeevi A; Cornwell R; Love R; Meyer K; Soergel P; Peterson K
Am J Respir Crit Care Med; 1999 Jan; 159(1):258-61. PubMed ID: 9872847
[TBL] [Abstract][Full Text] [Related]
5. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
Armstrong DS; Hook SM; Jamsen KM; Nixon GM; Carzino R; Carlin JB; Robertson CF; Grimwood K
Pediatr Pulmonol; 2005 Dec; 40(6):500-10. PubMed ID: 16208679
[TBL] [Abstract][Full Text] [Related]
6. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
von Bredow C; Birrer P; Griese M
Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
[TBL] [Abstract][Full Text] [Related]
8. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
9. Regional variability of lung inflammation in cystic fibrosis.
Meyer KC; Sharma A
Am J Respir Crit Care Med; 1997 Nov; 156(5):1536-40. PubMed ID: 9372672
[TBL] [Abstract][Full Text] [Related]
10. Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.
Griese M; von Bredow C; Birrer P
Electrophoresis; 2001 Jan; 22(1):165-71. PubMed ID: 11197168
[TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
Konstan MW; Hilliard KA; Norvell TM; Berger M
Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
14. The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10.
Dosanjh AK; Elashoff D; Robbins RC
J Interferon Cytokine Res; 1998 Oct; 18(10):851-4. PubMed ID: 9809620
[TBL] [Abstract][Full Text] [Related]
15. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
[TBL] [Abstract][Full Text] [Related]
16. Physiological concentration of calcium inhibits elastase-induced cleavage of a functional recombinant fragment of surfactant protein D.
Duvoix A; Mackay RM; Henderson N; McGreal E; Postle A; Reid K; Clark H
Immunobiology; 2011; 216(1-2):72-9. PubMed ID: 20378199
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for bronchiectasis in children with cystic fibrosis.
Sly PD; Gangell CL; Chen L; Ware RS; Ranganathan S; Mott LS; Murray CP; Stick SM;
N Engl J Med; 2013 May; 368(21):1963-70. PubMed ID: 23692169
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein A in bronchoalveolar lavage fluid.
van de Graaf EA; Jansen HM; Lutter R; Alberts C; Kobesen J; de Vries IJ; Out TA
J Lab Clin Med; 1992 Aug; 120(2):252-63. PubMed ID: 1500824
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
Nakamura H; Yoshimura K; McElvaney NG; Crystal RG
J Clin Invest; 1992 May; 89(5):1478-84. PubMed ID: 1569186
[TBL] [Abstract][Full Text] [Related]
20. Purification and biochemical characterization of pulmonary surfactant protein A of horses.
Hobo S; Ogasawara Y; Kuroki Y; Akino T; Yoshihara T
Am J Vet Res; 1999 Feb; 60(2):169-73. PubMed ID: 10048546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
